A case of hepatic portal venous gas due to viral gastroenteritis
Author(s): Mirmanesh M | Nguyen QS | Markelov A
Volume: 2013
Issue: default
Year: 2013




Novel drugs in the management of difficult-to-treat hepatitis C genotypes
Author(s): Cartwright EJ | Miller L
Volume: 2013
Issue: default
Year: 2013




Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
Author(s): Durango E | Dietrich C | Seitz HK | Kunz CU | Pomier-Layrargues GT | Duarte-Rojo A | Beaton M | Elkhashab M | Myers RP | Mueller S
Volume: 2013
Issue: default
Year: 2013




The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage
Author(s): Ehnert S | Lukoschek T | Bachmann A | Martinez Sanchez JJ | Damm G | Nussler NC | Pscherer S | Stöckle U | Dooley S | Mueller S | Nussler AK
Volume: 2013
Issue: default
Year: 2013




The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
Author(s): Danish FA | Yasmin S
Volume: 2013
Issue: default
Year: 2013




Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
Author(s): Kawanaka M | Nishino K | Nakamura J | Suehiro M | Goto D | Urata N | Oka T | Kawamoto H | Nakamura H | Yodoi J | Hino K | Yamada G
Volume: 2013
Issue: default
Year: 2013




Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
Author(s): Lau T | Ahmad J
Volume: 2013
Issue: default
Year: 2013




Natural history and management of primary biliary cirrhosis
Author(s): Al-Harthy N | Kumagi T
Volume: 2012
Issue: default
Year: 2012




Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
Author(s): Espul C | Benedetti L | Cuello H | Houillon G | Rasuli A
Volume: 2012
Issue: default
Year: 2012




Update on entecavir in the management of severe forms of Hepatitis B
Author(s): Sacco R
Volume: 2012
Issue: default
Year: 2012




Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
Author(s): Dhanasekaran R | Limaye A | Cabrera R
Volume: 2012
Issue: default
Year: 2012




Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites
Author(s): Kohlhaas A | Durango E | Millonig G | Bastard C | Sandrin L | Golriz M | Mehrabi A | Büchler MW | Seitz HK | Mueller S
Volume: 2012
Issue: default
Year: 2012




Epidemiology and treatment of autoimmune hepatitis
Author(s): Francque S | Vonghia L | Ramon A | Michielsen P
Volume: 2012
Issue: default
Year: 2012




Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection
Author(s): Obienu O | Nwokediuko SC
Volume: 2011
Issue: default
Year: 2011




Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Author(s): Ismail MH | Pinzani M
Volume: 2011
Issue: default
Year: 2011




Autonomic dysfunction in chronic liver disease
Author(s): Frith J | Newton JL
Volume: 2011
Issue: default
Year: 2011




Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH
Author(s): Darwiche H | Oh S-H | Steiger-Luther NC | Williams JM | Pintilie DG | Shupe TD | Petersen BE
Volume: 2011
Issue: default
Year: 2011




Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program
Author(s): Cervio G | Trentadue J | D´Agostino DE | Luque C | Giorgi MA | Armoni J | Debbag R
Volume: 2011
Issue: default
Year: 2011




A newborn liver mass that never existed: a somber reminder of embryonic ties between umbilical vein and portal venous system
Author(s): Haafiz A | Williams JL | Andres JM | Novak DA
Volume: 2011
Issue: default
Year: 2011




Rifaximin in the treatment of hepatic encephalopathy
Author(s): Iadevaia MD | Del Prete A | Cesaro C | Gaeta L | Zulli C | Loguercio C
Volume: 2011
Issue: default
Year: 2011




Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
Author(s): Locke JE | Singer AL
Volume: 2011
Issue: default
Year: 2011




Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
Author(s): Tomiyama Y | Yoshioka N | Yanai Y | Kawase T | Nishina S | Hara Y | Yoshida K | Korenaga K | Korenaga M | Hino K
Volume: 2011
Issue: default
Year: 2011




Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis
Author(s): Kent AP | Stylianou IM
Volume: 2011
Issue: default
Year: 2011




Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
Author(s): Bruno S | Savojardo D | Almasio PL | Mondelli MU
Volume: 2011
Issue: default
Year: 2011




Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
Author(s): Suad Abdeen | Samuel O Olusi | Sunila George
Volume: 2011
Issue: default
Year: 2011




Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes
Author(s): Katherine S Koch | Hyam L Leffert
Volume: 2010
Issue: default
Year: 2010




Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
Author(s): Nicole C Steiger-Luther | Houda Darwiche | Seh-Hoon Oh | et al
Volume: 2010
Issue: default
Year: 2010




Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes
Author(s): Kathleen Ponzetti | Melissa King | Anna Gates | et al
Volume: 2010
Issue: default
Year: 2010




Mechanism of the inhibitory effect of ghrelin in sepsis
Author(s): Asha Jacob | Rongqian Wu | Mian Zhou | et al
Volume: 2010
Issue: default
Year: 2010




Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
Author(s): M Gabrovska | F Geurs, S Ponette | et al
Volume: 2009
Issue: default
Year: 2009




A high prevalence of extreme hyperferritinemia in acute hepatitis patients
Author(s): Kazuhiro Kotoh | Akihiro Ueda | Masatake Tanaka | et al.
Volume: 2009
Issue: default
Year: 2009



